Privigen

Privigen is a medicine used to treat people who: * are at risk of infection because they do not have enough antibodies, particularly immunoglobulin G (IgG). Antibodies are protein in the blood that helps the body fight infections. This includes: * people who are born with a lack of antibodies (primary immunodeficiency syndrome, PID); * people who develop a lack of antibodies after birth (secondary immunodeficiency syndrome, SID), who have low levels of IgG and suffer from infections that are severe or keep coming back despite treatment with medicines used to treat infections. * have certain immune diseases caused by the body’s own immune system attacking normal tissues. In these diseases, Privigen helps regulate the activity of the immune system (immunomodulation). These include: * primary immune thrombocytopenia (ITP), where people do not have enough platelets (components that help the blood to clot) and are at high risk of bleeding; * Guillain\-Barré syndrome or chronic inflammatory demyelinating polyneuropathy (CIDP), inflammatory disorders of the nerves that cause muscle weakness and numbness; * Kawasaki disease, a disease mainly seen in children which causes inflammation of blood vessels; * multifocal motor neuropathy, a nerve disorder that causes weakness of the arms and legs. * need protection against measles before or after exposure because they are at risk and cannot receive, or should not receive, measles vaccination. The medicine contains the active substance human normal immunoglobulin.